Latest News and Press Releases
Want to stay updated on the latest news?
-
VIENNA, Dec. 16, 2024 (GLOBE NEWSWIRE) -- invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies for cancer, will be participating in JP Morgan week activities in...
-
VIENNA, Austria, Dec. 21, 2023 (GLOBE NEWSWIRE) -- invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies for cancer, will be participating in JP Morgan week...
-
VIENNA, Austria, Dec. 14, 2022 (GLOBE NEWSWIRE) -- invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies for cancer, today announces that CEO Peter...
-
SAN FRANCISCO, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Big3Bio is proud to announce the leading industry organizations that have signed on as inaugural partners and sponsors of BioWeekSF, the site...